Intrinsic Value of S&P & Nasdaq Contact Us

Armata Pharmaceuticals, Inc. ARMP AMEX

American Stock Excha • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+16.5%

Stock Statistics — ARMP

Armata Pharmaceuticals, Inc. (ARMP) has a market capitalization of $471.83M and trades at $12.88. The 52-week range is 0.9-16.34.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.7, Earnings Per Share (EPS) of $-4.80, annual revenue of $4.9M.

The stock has a beta of 1.40, operates in the Healthcare sector.

Trading Data
Current Price$12.88
52-Week Range0.9-16.34
Volume40.62K
Avg Volume (30D)53.06K
Market Cap$471.83M
Beta (1Y)1.40
Company
IPO Date1994-05-20
Employees60
CEODeborah L. Birx
CountryUS
ExchangeAmerican Stock Excha
CurrencyUSD
ISINUS04216R1023
CUSIP04216R102
Income (Latest Year)
Revenue$4.9M
Gross Profit$3.37M
EBITDA$-29.69M
Operating Income$-31.22M
Net Income$-173.8M
EPS$-4.80
EPS Diluted$-4.80
Shares Outstanding$36.24M
Balance Sheet (Latest Year)
Total Assets$76.88M
Current Assets$10.67M
Cash & ST Investments$8.69M
Total Liabilities$295.48M
Total Debt$288.02M
Net Debt$279.33M
Total Equity$-218.6M
Debt / Equity-1.32
Valuation Ratios
P/E Ratio-2.7
P/S Ratio96.21
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message